A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects
Clinical trial NCT04772365 · COMPLETED
Trial details
- NCT number
- NCT04772365
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2021-12-10
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.